Effects of Helicobacter pylori Infection on gastric mucin expression
Hyung Min Kang1, Nayoung Kim, Young Soo Park
1Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea.
Aims:
This study was performed to determine the gastric distributions of MUC5AC and MUC6 depending on Helicobacter pylori (H. pylori) infection, and to evaluate whether the expressions of MUC5 and MUC6 change in H. pylori-associated gastroduodenal diseases. In addition, MUC5AC and MUC6 expressional changes were investigated before and after H. pylori eradication.
Methods:
In the 224 individuals (136 H. pylori-positive and 88 H. pylori-negative) who came from control (N=48), duodenal ulcer (N=35), benign gastric ulcer (N=61), dysplasia plus stomach cancer (N=80) groups, MUC5AC and MUC6 expressions were determined by immunohistochemical staining in the antrum and body, respectively. This staining for MUC5AC and MUC6 were reperformed in 113 of the 136 H. pylori-positive patients after successful H. pylori eradication by proton pump inhibitor-based triple therapy.
Results:
(1) No difference was found between the H. pylori-positive and negative groups in terms of MUC5AC expression. In contrast, MUC6 expression was significantly lower in the H. pylori-positive group than in the H. pylori-negative group in the gastric body. Moreover, reduced MUC6 expression increased to the H. pylori-negative level after eradication. (2) Expressions of MUC5AC and MUC6 were significantly lower in the dysplasia plus cancer group than those of control in case of H. pylori positive. Similarly, MUC5AC and MUC6 expressions were significantly lower in the presence of atrophic gastritis with intestinal metaplasia in case of H. pylori positive. (3) Aberrant expressions of MUC6 in foveolar cells were observed in both antrum (11.3%) and body (5.3%) only in the H. pylori-positive group, but this reverted to normal after H. pylori eradication.
Conclusion:
These results suggest that H. pylori infection causes alterations of mucin expression, closely related with the development of gastric atrophy with intestinal metaplasia, probably contributing to carcinogenesis.
Insights
Helicobacter pylori infection significantly reduces MUC6 expression in the stomach, particularly in cases of precancerous lesions. Eradicating H. pylori restores MUC6 levels, suggesting a role in gastric disease development.
Area of Science:
- Gastroenterology and Molecular Biology
- Investigates the role of mucin glycoproteins in the pathogenesis of H. pylori-associated gastroduodenal diseases.
Background:
- Mucins, such as MUC5AC and MUC6, are critical components of the gastric mucosal barrier.
- Helicobacter pylori infection is a major risk factor for various gastroduodenal pathologies, including ulcers, atrophic gastritis, and gastric cancer.
Purpose of the Study:
- To determine the gastric distribution of MUC5AC and MUC6 in relation to H. pylori infection status.
- To evaluate changes in MUC5AC and MUC6 expression in H. pylori-associated gastroduodenal diseases.
- To assess the impact of H. pylori eradication on MUC5AC and MUC6 expression.
Main Methods:
- Immunohistochemical staining was used to assess MUC5AC and MUC6 expression in gastric biopsies from 224 individuals (H. pylori-positive and negative).
- Patients were categorized into control, duodenal ulcer, benign gastric ulcer, and dysplasia plus stomach cancer groups.
- Expression levels were re-evaluated in a subset of H. pylori-positive patients after successful eradication therapy.
Main Results:
- MUC6 expression was significantly lower in H. pylori-positive individuals compared to H. pylori-negative individuals, particularly in the gastric body.
- MUC5AC and MUC6 expression were notably reduced in H. pylori-positive patients with dysplasia plus cancer and atrophic gastritis with intestinal metaplasia.
- Aberrant MUC6 expression in foveolar cells was observed in H. pylori-positive individuals but normalized after eradication.
Conclusions:
- H. pylori infection induces significant alterations in gastric mucin expression, specifically a reduction in MUC6.
- These mucin expression changes are closely linked to the development of gastric atrophy with intestinal metaplasia.
- The findings suggest a potential role for H. pylori-induced mucin alterations in the process of gastric carcinogenesis.
Related Concept Videos
Gastritis II: Pathophysiology
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...


